China Biologic Products Stock News

China Biologic Products (NASDAQ:CBPO) will post its quarterly earnings results after the market closes on Thursday, March 12th. Individual interested in registering for the company’s earnings confer

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin

BidaskClub upgraded shares of China Biologic Products (NASDAQ:CBPO) from a sell rating to a hold rating in a research note issued to investors on Wednesday, BidAskClub reports. Separately, ValuEngine

NEW YOKR/HONG KONG (Reuters) - China's Centurium Capital, a big backer of domestic startup Luckin Coffee, is set to reach the first close of fundraising for its latest private equity fund with about $

NEW YOKR/HONG KONG, March 6 (Reuters) - China's Centurium Capital, a big backer of domestic startup Luckin Coffee, is set to reach the first close of fundraising for its latest private equity fund wit

China Biologic Products (NASDAQ:CBPO) is scheduled to be announcing its earnings results after the market closes on Thursday, March 12th. Investors that wish to register for the company’s conference

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company

First Trust Advisors LP reduced its position in shares of China Biologic Products Holdings Inc (NASDAQ:CBPO) by 11.2% in the fourth quarter, according to the company in its most recent filing with the

China Biologic Products Holdings Inc (NASDAQ:CBPO) was the recipient of a large decrease in short interest in the month of February. As of February 14th, there was short interest totalling 432,600 sha

China Biologic Products (NASDAQ:CBPO) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Tuesday, BidAskClub reports. Separately, ValuEngine lowe

The